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Abstract
Background: Members of the mammalian nucleotide binding domain, leucine-rich repeat (LRR)-containing
receptor (NLR) family of proteins are key modulators of innate immunity regulating inflammation. Our previous
work has shown that among the members of this family, NLRP1/NALP1, present in neurons, plays a crucial role in
inflammasome formation and the production of the inflammatory cytokines interleukin (IL) -1b and IL-18 after
various types of central nervous system injury.
Results: We investigated whether age-related cognitive decline may involve a heightened inflammatory response
associated with activation of the NLRP1 inflammasome in the hippocampus. Young (3 months) and aged (18
months) male Fischer 344 rats were tested in a spatial acquisition task via Morris water maze. Following behavioral
testing, hippocampal lysates were assayed for expression of NLRP1 inflammasome components and inflammatory
cytokines. Hippocampal lysates from aged rats showed significantly higher levels of NLRP1 inflammasome
constituents, caspase-1, caspase-11, the purinergic receptor P2X7, pannexin-1 and X-linked inhibitor of apoptosis
(XIAP) than lysates from younger animals. Following treatment with probenecid, an inhibitor or pannexin-1, aged
animals demonstrated reduction in inflammasome activation and improvement in spatial learning performance.
Conclusions: Our behavioral findings are consistent with increases in IL-1b and IL-18 that have been previously
shown to correlate with spatial learning deficits. Probenecid reduced activated caspase-1 and ameliorated spatial
learning deficits in aged rats. Thus, aging processes stimulate activation of the NLRP1 inflammasome and secretion
of IL-1b and IL-18 that may contribute to age-related cognitive decline in the growing elderly population.
Moreover, probenecid may be potentially useful as a therapy to improve cognitive outcomes in the aging
population.
Background
Inflammatory immune responses are induced in the
immune privileged central nervous system (CNS) by
aging and neurodegenerative diseases, but CNS cells and
molecular mechanisms that regulate innate immunity
are poorly defined. One prominent and early inflamma-
tory cytokine present in aged and diseased tissue is IL-
1b that may contribute to secondary cell death. Despite
the central function attributed to the immune system in
aging and neurodegenerative diseases, the initiating sig-
naling pathways that ultimately lead to the activation of
the CNS innate immune system are unclear.
T h ei n f l a m m a t o r yc y t o k i n eI L - 1 b is normally pro-
duced and stored in the cytosol as inactive pro-IL-b that
is rapidly cleaved by caspase-1, which then elicits
inflammation after being released from the cell. A num-
ber of host-derived molecules that alert the innate
immune system to cell injury and tissue damage activate
the inflammasome [1]. These molecules called “danger-
associated molecular patterns” include ATP [2] and high
extracellular potassium [3]. Our recent work has shown
that the NLRP1 inflammasome in neurons plays a cru-
cial role in the innate CNS immune response induced
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contributes to inflammatory cytokine production and
cognitive impairment due to aging remains largely
undefined.
Amplified and prolonged inflammatory responses in
the aged brain have been reported to promote cognitive
and behavioral impairments [7,8], and clinical studies of
elderly patients with infections reveal increases in the
occurrence of delirium [9,10]. Moreover, elderly patients
with prolonged infections are also prone to an increased
probability of developing dementia [11] and increased
mortality rate [12]. Thus, the prolonged, amplified pro-
duction of inflammatory molecules may underlie a
heightened neuroinflammatory response in the aged
brain leading to cognitive impairments.
In the present study, we found that the NLRP1
inflammasome is involved in age-induced activation of
caspase-1, and the release of mature IL-1b and IL-18 in
the hippocampus. Moreover, aging induced increased
expression and altered cellular distribution of critical
components of the NLRP1 inflammasome in hippocam-
pal neurons. These changes corresponded to age-related
cognitive deficits in spatial learning. Treatment with
probenecid, an anti-inflammatory drug commonly used
for gout, reduced NLRP1 inflammasome activation and
improved spatial learning performance in aged rats.
Thus, it appears that heightened NLRP1 inflammasome
activity is induced by the natural aging process resulting
in increased inflammatory cytokine production and cog-
nitive impairment that can be attenuated by inhibition
of inflammasome activation.
Results
Aged animals perform poorly on a hippocampal-
dependent spatial learning task
To assess age-related deficits in hippocampal-depen-
dent spatial learning, young and aged rats were tested
in a 3-day spatial acquisition task via Morris water
maze (Figure 1). Mean (+/- standard error mean
(SEM)) values were determined for each testing day on
latency to platform (Figure 1A) and for testing day 3
for mean path length (Figure 1B) For days 2 and 3,
young rats located the hidden platform with lower
latencies (day 2: 17.1 +/- 1.4 s, day 3: 9.4 +/- 0.7 s)
than aged rats (day 2: 35.8+/- 1.3 s, day 3: 29.3 +/- 1.4
s) (Figure 1A). Additionally, mean path-length for
young rats (502 +/- 48 cm) was significantly shorter
than for aged rats (1487 +/- 132 cm) on day 3 of test-
ing. Aged rats are consistently impaired in learning the
location of the escape platform [13]. Therefore, our
results were similar to previous findings that aged rats
demonstrate spatial learning impairment compared to
young rats.
Aging increases hippocampal expression of NLRP1
inflammasome components in the hippocampus
The NLRP1 inflammasome in neurons constitutes a
multiprotein complex consisting of caspase-1, caspase-
11, apoptosis-associated-speck-like protein containing a
caspase recruitment domain (ASC), NLRP1, P2X7, pan-
nexin-1 and XIAP [4]. Upon inflammasome activation
caspase-1 is cleaved into active fragments that process
pro-IL-1b and pro-IL-18 into active IL-1b and IL-18
Figure 1 Aged animals perform poorly on a hippocampal dependent spatial learning task. Average latency to platform on day 1-3 of
spatial acquisition testing via Morris water maze for young (closed circles) and aged rats (open circles) (A). Mean path length for young and
aged rats on final day of testing (B). Data are presented as mean +/- SEM. *p < 0.01 compared with young. n = 20 per group.
Mawhinney et al. BMC Neuroscience 2011, 12:123
http://www.biomedcentral.com/1471-2202/12/123
Page 2 of 10[14]. To determine whether aging alters expression of
NLRP1 inflammasome components, protein lysates of
young and aged hippocampi were analyzed for levels of
inflammatory caspases and key inflammasome proteins
(Figure 2). Hippocampal lysates from aged animals con-
tained significantly higher levels of cleaved fragments of
caspase-1 (p = 0.006), caspase-11 (p = 0.011), and XIAP
(p = 0.0021), and increased levels of the P2X7 receptor
(p = 0.001) and pannexin-1 (p = 0.049) than lysates
from young rats. Levels of NLRP1 and ASC were not
altered in the aged animals. Thus, aging stimulates the
expression of some of the key components of the
NLRP1 inflammasome in the hippocampus, suggesting
an involvement of the inflammasome in the aging
process.
Aging induces alterations in expression patterns of
pannexin-1 and the purinergic receptor P2X7 in the
hippocampus
In our previous work, we showed that the pore-forming
protein pannexin-1 can transport extracellular NLRP1
stimuli into the cytoplasm of neurons and astrocytes
after P2X7 receptors bind ATP [3], suggesting that K
+
ion influx through pannexin-1 pores may initiate activa-
tion of the NLRP1 inflammasome. To establish whether
aging induces changes in the pattern of expression of
caspase-1, pannexin-1 and the P2X7 receptor, hippo-
campi from young (n = 4) and aged rats (n = 6) were
examined by confocal microscopy. Brain sections under-
went immunohistochemical procedures followed by con-
focal microscopy. Images indicate that aging results in
altered staining patterns of inflammasome proteins in
the hippocampus (Figure 3). In young rats, caspase-1
immunoreactivity (red) was present in NeuN positive
nuclei (green) in a diffuse expression pattern, while
intense caspase-1 staining was seen in hippocampal neu-
rons of aged rats located in the cell nucleus and cyto-
plasm. The increased intensity of caspase-1 staining was
consistent across aged animals. A more striking altera-
tion was observed in the immunostaining of pannexin-1
and P2X7 receptors. In aged rats, immunoreactivity of
both inflammasome proteins was markedly enhanced,
and intense patchy staining was seen in the neuronal
soma near or associated with the plasma membrane
(arrows). The intensity of this patchy staining was
greater in the apical portion of the hippocampal neuro-
nal membrane (arrows) than in the basal portion. The
staining patterns of aged animals were more variable
than young animals. However, the appearance of intense
patches of pannexin-1 and P2X7 receptors was present
in the hippocampus of all six aged animals analyzed.
Labeling patterns were similar throughout the hippo-
campus for young and aged rats. These results demon-
strate that aging induces dramatic alterations in the
expression patterns of caspase-1, pannexin-1 and P2X7
receptors in hippocampal neurons.
Figure 2 Aging alters expression of NLRP1 inflammasome components.R e p r e s e n t a t i v ei m m u n o b l o t sand densitometric analysis of
immunoblots for caspase-1 (Casp1), caspase-11 (Casp11), NLRP1, ASC, cleaved XIAP, P2X7 receptor (P2X7R) and pannexin-1 (PanX1) in brain
lysates of young (Y) and aged (A) animals. Protein levels of cleaved caspase-1 and -11 are higher in aged animals compared to young. Protein
levels of NLRP1 and ASC did not change with age whereas P2X7 receptor, the pannexin-1 protein and the cleaved fragment of XIAP are higher
in aged animals than in young animals. b-Tubulin was used as an internal standard and control for protein loading. Data are presented as mean
+/- SEM. *p < 0.05, **p < 0.01, ***p < 0.005 compared with young. n = 6 per group.
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Page 3 of 10Figure 3 Aging induces alterations in protein expression patterns of Caspase-1, pannexin-1 and P2X7R in hippocampal neurons.
Confocal images show hippocampal neurons in the CA3 region of young and aged animals. Sections were stained for caspase-1, pannexin-1
and P2X7 (red) and the neuronal marker NeuN (green). In aged animals, the immunoreactivity of caspase-1, P2X7 and pannexin-1 are increased
in neurons of the hippocampus compared to young animals with P2X7 and pannexin-1 showing a polarized distribution near the somatic
membrane (arrows). Bar=20 μm.
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Page 4 of 10Probenecid treatment attenuates age-related elevation in
NLRP1 inflammasome components
Probenecid was previously shown to block inflamma-
some activity, specifically by inhibiting Pannexin 1 [15].
Here we show a significant decrease in cleaved caspase-
1 (p = 0.0426, Figure 4B), P2X7 receptor (p = 0.0258,
Figure 4B), and Pannexin1 (p = 0.004, Figure 4B) pro-
tein expression in the hippocampus following probene-
cid treatment in aged rats consistent with lower protein
levels of IL-1b and IL-18. Treatment with probenecid
also improved spatial learning performance in aged rats.
Probenecid treated aged rats demonstrated lower latency
to platform (p = 0.0287, Figure 4C) and mean path
length (p = 0.015, Figure 4D) than vehicle-treated age-
matched controls. These results demonstrate that treat-
ment with probenecid reduces age-related increases in
NLRP1 inflammasome activation in the aged hippocam-
pus and ameliorates age-related cognitive deficits.
Discussion
I nt h i ss t u d yw eh a v es h o w nf o rt h ef i r s tt i m ea na g e -
related heightened activati o no ft h eN L R P 1i n f l a m m a -
some system associated with increased inflammation
and cognitive impairment in the hippocampus of aged
rats. Our data show that aging promotes NLRP1 inflam-
masome activity resulting in processing of caspase-1 and
upregulation of caspase-11. The neuronal NLRP1
inflammasome is a multiprotein complex consisting of
inflammatory caspases-1 and -11, NLRP1, the adaptor
protein ASC and the inhibitor of apoptosis protein
XIAP. Assembly and activation of the NLRP1 inflamma-
some involves caspase -1 and -11 activation that subse-
quently leads to maturation and secretion of IL-1b and
IL-18 [4-6]. Once secreted, these cytokines initiate
inflammatory processes throughout the CNS. In addi-
t i o n ,w eh a v ep r e v i o u s l ys h o w nt h a tt h eN L R P 1i n f l a m -
masome interacts with the pore forming protein
Figure 4 Probenecid reduces protein expression of NLRP1 inflammasome and ameliorates spatial learning deficits in aged rats. (A)
Representative immunoblots of cleaved caspase-1, pannexin1 and P2X7R in hippocampal lysates of vehicle (Veh)-treated and probenecid (Pr)-
treated 18-month-old rats. b-tubulin was used as an internal control. (B) Densitometric analysis of immunoblots from brain lysates of cleaved
caspase-1 (Casp1), P2X7 receptor (P2X7R), and pannexin1 (PanX1). (C-D) Aged animals underwent behavioral testing following either probenecid
or vehicle treatment. (C) In a hippocampal-dependent spatial learning task via Morris water maze, latency to platform was measured on days 1-3
and 8-10. Probenecid-treatment improved latency to platform measured on the final day of testing (D) Mean path length was determined on
day 10 of testing and probenecid-treated rats demonstrated significantly shorter mean path lengths than vehicle-treated controls. Drug
treatment was administered twice daily for 3 days (days 7-9). Data are presented as mean +/- SEM *p < 0.05, **p < 0.005 compared to vehicle. N
= 6-8/per group.
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Page 5 of 10pannexin-1 and the purinergic receptor P2X7 [3-5].
Aging leads to significant cognitive impairment in hip-
pocampal dependent spatial learning tasks [13] that may
be associated with increased inflammatory cytokine pro-
duction resulting from NLRP1 activation. Thus, the
NLRP1 inflammasome constitutes an important arm of
the innate CNS inflammatory response associated with
aging in the hippocampus.
IL-1b is synthesized by neuronal and glial cells [16]
and is released in response to injury, insult and stress
[17-20]. We found that hippocampal neurons, which are
generally not associated with immune functions, express
NLRP1 inflammasome proteins. These results are in
agreement with previous findings that show NLRP1
expression in neurons of the spinal [4] and cerebral cor-
tex [5,6] after injury. Moreover, the cellular distribution
of NLRP1 inflammasome proteins changed during the
aging process. Our results suggest that NLRP1 inflam-
masome activity is fundamental for the processing of IL-
1b and IL-18 and for the innate inflammatory response
in aged neurons. However, ASC, caspase-1 and caspase-
11 are also present in astrocytes, oligodendrocytes and
microglial cells. Therefore, characterization of the com-
position and subcellular localization of inflammasomes
in glia may provide a clearer insight into the mechan-
isms leading to cytokine secretion and cell death caused
by caspase-1 with aging. Thus, aging-induced NLRP1
inflammasome activation in neurons could lead to reac-
tive gliosis in neighboring cells mediated by IL-1 cyto-
kines released from neurons.
T h ei n f l a m m a s o m ei nh i p p o campal neurons is a pro-
tein complex containing NLRP1 as a scaffolding protein
that activates caspase-1 to promote IL-1b and IL-18
maturation associated with aging (see additional file 1
for immunoblotting results of IL1b and IL-18 in young
and aged rats). Although the total levels of NLRP1 and
ASC in lysates did not change significantly with aging,
the proportions of other key components that form the
NLRP1 inflammasome increased. These findings are in
agreement with our previous work on NLRP1 inflamma-
some regulation following spinal cord [4] and traumatic
brain injury [5] that showed similar changes in NLRP1
components after injury. Moreover, the inflammasome
in normal tissues is speculated to be in an inactive state
by binding to a putative inhibitor [21], but the nature of
this inhibitor has not been identified. We previously
suggested that XIAP in the NLRP1 inflammasome com-
plex may inhibit caspase-1 activity preventing the activa-
tion and processing of IL-1b and IL-18 [3-5]. Moreover,
aging-induced activation of the inflammasome was
found to be associated with cleavage of XIAP into frag-
ments. Cleavage of XIAP produces an N-terminal BIR1-
2 fragment with reduced ability to inhibit caspases
[22-24]. Therefore, aging-related XIAP cleavage may
reduce the threshold for activation of caspase-1, leading
to processing and secretion of IL-1b and IL-18.
Our results are in agreement with earlier studies that
demonstrate systemic administration of IL-1b results in
impaired hippocampal-dependent consolidation of mem-
ories in a fear-conditioning paradigm [25-27]. Neutrali-
zation of IL-1b blocked the deficits in hippocampal-
dependent memory consolidation [25,28]. Other reports
demonstrate that the aging process results in elevated
concentrations of IL-1b at 15 months of age [29],
whereas hippocampal IL-18, a closely related IL-1 proin-
flammatory cytokine increases in rats as early as 9
months of age [29]. Additionally, the age-specific eleva-
tion in these proinflammatory cytokines may influence
deficits in long-term potentiation [30,31]. Further stu-
dies are needed to determine whether the NLRP1
inflammasome-induced activation and increased IL-1b
and IL-18 observed in our study influence deficits in
synaptic transmission leading to cognitive decline.
To date, microbial pathogen-associated molecules and
toxins have been identified as key triggers of activation
of inflammasomes [1,2]. However, recently, environmen-
tal [32-34] and neurodegenerative [35,36] stimuli have
been identified that lead to IL-1b release by means of
inflammasomes. With respect to the latter, researchers
[36] demonstrated that the NLRP3 inflammasome is
activated by fibrous particles of amyloid-beta that results
in cleavage of caspase-1 and production of IL-1b in
microglia and macrophages. However, it is not known
whether amyloid-beta activates the NLRP1 inflamma-
some in neurons thus further enhancing production of
IL-1b in the aging brain. Our recent work demonstrated
that the pore-forming protein pannexin-1 in neurons
and astrocytes transports the extracellular K
+ ions to sti-
mulate the NLRP1 inflammasome in the cytoplasm after
P2X7 receptors bind ATP [3]. Thus, it is possible that
the aging-induced increases in pannexin-1 and P2X7
expression in hippocampaln e u r o n so b s e r v e di nt h i s
study may facilitate K
+ influx, thereby initiating NLRP1
inflammasome activation.
Probenecid is an inhibitor of renal tubular transpor-
ters, regularly used in the treatment of gout. However,
probenecid-sensitive transporters are found throughout
t h eb o d yi n c l u d i n gt h ei m m u n ep r i v i l e g e dC N S
[3,37-40]. Using in vivo microdialysis techniques, one
study examined the transport of probenecid across the
blood brain barrier (BBB), reporting the presence of
probenecid in cerebrospinal fluid, brain interstitial fluid,
and brain tissue tissue [41]. Therefore, in the present
study, we chose a course of treatment based on the
recent identification of probenecid as an inhibitor of
inflammasome activation in neurons and astrocytes
[3,15]. We were specifically interested in the effect of
probenecid treatment in improving cognitive deficits
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Page 6 of 10observed in aged rats. Young rats did not demonstrate
impairment in spatial learning and therefore were not
tested in the probenecid study. We hypothesized that
probenecid may reduce cognitive impairment in aged
rats via inhibition of inflammasome activation in the
hippocampus. Accordingly, our findings support the use
of probenecid as an anti-inflammatory therapy in the
CNS. The aging-induced elevation in inflammasome
activation in the hippocampus was attenuated by probe-
necid treatment, resulting in improved cognitive out-
comes for aged rats in vivo.
Conclusions
Our main findings suggest that the aged brain experi-
ences heightened activation of the NLRP1 inflammasome
system with resultant increases in caspase 3 activation
and inflammatory cytokines IL-1b and IL-18 correspond-
ing to impaired spatial learning in aged rats. Since these
cytokines contribute to the pathology of different neuro-
degenerative diseases such as Alzheimer disease [42,43]
and Parkinson disease [44]. and are involved in a positive
feedback mechanism in which more cytokines are pro-
duced upon cytokine release [45], it is reasonable to
hypothesize that interfering with inflammasome activa-
tion may prove to be beneficial in delaying development
of age-related neurodegenerative diseases in which the
IL-1 inflammatory response plays a pathogenic role.
Additionally, our results suggest that inhibition of
inflammasome activation in the aged brain, with systemic
probenecid treatment, reduces caspase-1 activation and, in
turn, reduces inflammatory cytokines, IL-1b and IL-18,
which have been linked to age-related cognitive decline.
Because probenecid is an inhibitor of protein transporters
found throughout the body [3,37-40], it is possible that the
effect of probenecid on cognitive performance may be
multifactorial. Additionally, one must consider the poten-
tial exerted by probenecid to increase levels of neuropro-
tectants such as kynurenic acid (KYNA) when
administered with the precursor of KYNA, L-kynurennine
(L-KYN) in toxic disease models in rats [46-49]. The effect
of probenecid on KYNA levels in the aged brain deserves
further study. However, our data suggest that therapeutic
intervention with probenecid alone or another agent that
inhibits the NLRP1 inflammasome, with corresponding
reduction in proinflammatory cytokines, may improve
overall cognitive outcomes and reduce symptoms of nor-
mal cognitive aging. In addition, the therapeutic use of
probenecid in young and aged animals with neuroinflam-
mation due to disease or injury also deserves further study.
Methods
Animals
A total of 20 young (3 months, 220-250 grams) and 36
aged (18 months, 375-450 grams) male Fischer rats were
acquired from Charles River Laboratories and the
National Institute on Aging Colony respectively for this
study. Animals were maintained on a 12:12 h (light: dark)
cycle and given food ad libitum. All animals were housed
according to National Institutes of Health and United
States Department of Agriculture guidelines. The Institu-
tional Animal Care and Use Committee of the University
of Miami approved all animal procedures. Animals were
submitted to behavioral testing or biochemical analysis
following a 2 week acclimation period under standard
laboratory conditions. For behavioral testing, n = 20/age
group. For biochemical analyses, n = 6/age group.
Probenecid treatment
Sixteen aged (18 month old) male Fischer 344 rats were
randomized to receive probenecid (Alfa Aesar) or saline
vehicle at a dose of 0.5 mg/kg by intraperitoneal (I.P.)
injection twice daily for 3 days.
Behavioral Testing
Spatial acquisition and retention was assessed using a
Morris water maze navigational task [50]. A circular
tank (122 cm diameter) in a room with visual cues was
filled with water (21°C) made opaque with white paint.
A platform (9.3 cm diameter) hidden just beneath the
water surface was placed in the northeast quadrant. The
path length (i.e., the distance traveled until locating the
platform) and latency to find the platform were
recorded and analyzed with Ethovision software (Noldus
Information Technology). Latency and mean path length
to platform was measured for days 1 - 3 of testing. Each
day, the animals were given four trials and an average
was determined. The animal was placed randomly at
each of four starting points (north, south, east, and
west) and allowed 60 s to find the hidden platform.
After locating the platform, the animal remained on the
platform for 10 s. If the animal did not locate the plat-
form within 60 s, it was placed on the platform for 10 s.
Following each trial, the animal was placed in a cage
kept warm with an infrared heating lamp. Inter-trial
interval was approximately 4 min. Testing days 1-3 for
latency and day 3 for path length are reported for reten-
tion of the task. For the probenecid experiment, animals
were tested on days 1 - 3 and 8 - 10. Probenecid or sal-
ine vehicle was administered on days 7 - 9. Behavioral
testing was conducted similarly to the testing above
with the placement of the hidden platform moved to the
southwest quadrant for the second testing session.
Latency to platform is reported for days 1-3 and 8-10.
Mean path lengths are reported for day 10.
Immunoblotting
Animals were anesthetized with 3% isoflurane/70% N2O/
30% O2 for 5 minutes then sacrificed by decapitation.
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ine and frozen in liquid nitrogen within 3 min of decapi-
tation, and stored at -80 deg C. For detection of
inflammasome components, receptors and inflammatory
cytokines, a section of the right hippocampus of young
and aged animals was homogenized in extraction buffer
( 2 0m MT r i s - H C l ,p H :7 . 5 ,1 5 0m MN a C l ,1 %T r i t o nX -
100; 1 mM ethylenediaminetetraacetic acid, 1 mM ethy-
lene glycol tetraacetic acid, 2.5 mM pyrophosphate, 1
mM -glycerophosphate) with protease and phosphatase
inhibitors cocktail (Sigma). Proteins were resolved in 10-
20% Tris-HCl Criterion precasted gels (Bio-Rad), trans-
ferred to polyvinylidene difluoride membranes (Applied
Biosystems) and placed in blocking buffer (PBS, 0.1%
Tween-20, 0.4% I-Block (Applied Biosystems) and then
incubated for 1 h with: anti-IL-1b (1:1000, National Can-
cer Institute - 3ZD MAb), anti-IL-18 (1:1000, Abcam
ab37640), anti-caspase-1 (1:1000, Imgenex - IMG5028),
anti-caspase-11 (1:1000, Alexis Biochemicals, Axxora -
ALX-210-818), anti-ASC (1:5000, Bethyl Laboratories, as
described in de Rivero Vaccari et. al. 2008), anti-NLRP1
(1:1000, Bethyl Laboratories as described in de Rivero
Vaccari et al., 2008), anti-pannexin-1 (1:1000, Invitrogen
- 488100) and anti-P2X7 (1:1000, Alomone Labs - APR-
004) followed by appropriate secondary horseradish per-
oxidase (HRP)-linked antibodies (Cell Signaling). Visuali-
zation of signal was enhanced by chemiluminescence
using a phototope-HRP detection kit (Cell Signaling). To
control for protein loading, immunoblots were stripped
with Restore, Western blot stripping buffer (Pierce) and
blotted for b-tubulin (1:5000, BD Biosciences Pharmin-
gen). Quantification of band density was performed using
UN-Scan-IT gel™ quantifying software (Silk Scientific),
and data were normalized to b-tubulin. However IL-1b
and IL-18 immunoblots were not quantified because
these two proteins are secreted cytokines.
Perfusion Fixation
Following behavior testing, young and aged animals
were anesthetized with 3% isoflurane/70% N2O/30% O2
for 5 minutes and intracardially perfused with cold
heparinized normal saline solution and subsequently
with 4% paraformaldehyde solution. Brains were
removed and placed in 4% paraformaldehyde at 4°C for
20 h. Then brains were placed in 20% sucrose in 0.1 M
PBS and stored at 4° until sectioning through the hippo-
campus from 2.4 to 5.8 mm posterior to bregma. Sec-
tions were taken with a thickness of 50 μμm.
Immunohistochemistry
Frozen sections were blocked by treatment with normal
goat serum (Vector Laboratories), rinsed with 0.1 M phos-
phate-buffered saline (PBS;p H7 . 4 )a n di n c u b a t e do v e r -
night at 4°C with primary antibodies against the same
proteins analyzed by immunoblotting at a dilution of
1:500. To determine the precise cellular distribution of
caspase-1, pannexin-1 and P2X7, sections were double
stained with the neuron specific marker mouse anti-neu-
ronal nuclei (NeuN; Chemicon) and anti-caspase-1
(Upstate), anti-P2X7 (Alomone Labs) and anti-pannexin-1
(Invitrogen). Alexa-Fluor secondary antibody conjugates
(Molecular Probes) were used as secondary antibodies.
Controls using an irrelevant antibody of the same isotype
were run in parallel to evaluate antibody specificity.
Statistical Analysis
Data are expressed as mean +/- standard error
(+/-SEM). Statistical comparisons between young and
aged groups, and treatment groups were made using
one-way analysis of variance, or repeated measures ana-
lysis of variance followed by Tukey’s multiple compari-
son tests depending on the outcome measure. P-values
of significance used were p < 0.05.
Additional material
Additional file 1: Aging induces processing of IL-1b and IL-18 in the
hippocampus. Representative immunoblot analysis of hippocampal
brain lysates of young (Y) and aged (A) animals. Brain lysates were
immunoblotted with antibodies against IL-1b and IL-18. b-Tubulin was
used as an internal standard and control for protein loading. Previous
findings have shown that IL-1 cytokines in the brain are associated with
the aging process. To establish whether aging activates these pro-
inflammatory cytokines in the hippocampus, protein lysates from young
and aged rats were analyzed for IL-1b and IL-18 by immunoblotting
procedures. The levels of active, processed forms of IL-1b and IL-18 were
higher in the aged animals than their younger counterparts, thus
indicating that aging induces activation of these inflammatory cytokines
in the hippocampus. Unlike IL-1a, IL-1b and IL-18 are cytokines that are
active only after inflammasome processing. Therefore, since IL-1b and IL-
18 are secreted cytokines quantification of these cytokines was not done
for it would represent an inaccurate estimation due to the inability to
determine the amount of IL-1 cytokines that are still in the cell and the
amount that has been secreted. Instead, inflammasome activation was
determined by measuring the protein levels of caspase-1 (See Figure 2).
Abbreviations
ASC: Apoptosis-associated-speck-like protein containing a caspase
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